Open Access

Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis

  • Authors:
    • Ping Zhang
    • Le Su
    • Feifan Ma
    • Xiuyu Ji
    • Yue Su
    • Qiulin Yue
    • Chen Zhao
    • Song Zhang
    • Xin Sun
    • Lin Zhao
  • View Affiliations

  • Published online on: December 13, 2021     https://doi.org/10.3892/mmr.2021.12568
  • Article Number: 52
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ulcerative colitis (UC) is a global disease, characterized by periods of relapse that seriously affects the quality of life of patients. Oligosaccharides are considered to be a prospective strategy to alleviate the symptoms of UC. The present study aimed to evaluate the effect of weilan gum oligosaccharide (WLGO) on a mouse UC model induced by dextran sulfate sodium (DSS). WLGO structural physical properties were characterized by electrospray mass spectrometry and fourier tansform infrared spectroscopy. MTT assays were performed to evaluate the non‑toxic concentration of WLGO. RT‑qPCR and ELISAs were conducted to determine the levels of inflammatory factors. The clinical symptoms and mucosal integrity of the DSS‑induced UC model were assessed by DAI and histological assessment. LPS‑induced Caco‑2 cells and DSS‑induced UC mice were used to explore the effects of WLGO on UC. Treatment of the mice with 4.48 g/kg/day WLGO via gavage for 7 days significantly relieved the symptoms of DSS‑induced UC model mice, whereas significant effects were not observed for all symptoms of DSS‑induced UC in the WLGO‑low group. The disease activity index score was decreased and the loss of body weight was reduced in DSS‑induced UC model mice treated with WLGO. Moreover, colonic damage and abnormally short colon length shortenings were relieved following WLGO treatment. WLGO treatment also reduced the concentration and mRNA expression levels of proinflammatory cytokines, including interleukin‑1β, interleukin‑6 and tumor necrosis factor α, in DSS‑induced UC model mice and lipopolysaccharide‑treated Caco‑2 cells. These results indicated that WLGO may be an effective strategy for UC treatment.
View Figures
View References

Related Articles

Journal Cover

February-2022
Volume 25 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang P, Su L, Ma F, Ji X, Su Y, Yue Q, Zhao C, Zhang S, Sun X, Zhao L, Zhao L, et al: Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis. Mol Med Rep 25: 52, 2022
APA
Zhang, P., Su, L., Ma, F., Ji, X., Su, Y., Yue, Q. ... Zhao, L. (2022). Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis. Molecular Medicine Reports, 25, 52. https://doi.org/10.3892/mmr.2021.12568
MLA
Zhang, P., Su, L., Ma, F., Ji, X., Su, Y., Yue, Q., Zhao, C., Zhang, S., Sun, X., Zhao, L."Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis". Molecular Medicine Reports 25.2 (2022): 52.
Chicago
Zhang, P., Su, L., Ma, F., Ji, X., Su, Y., Yue, Q., Zhao, C., Zhang, S., Sun, X., Zhao, L."Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis". Molecular Medicine Reports 25, no. 2 (2022): 52. https://doi.org/10.3892/mmr.2021.12568